Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms
Acupuncture for Long COVID Neuropsychiatric Symptoms: a Pragmatic,Randomized Clinical Trial
Hong Kong Baptist University
160 participants
Jul 30, 2023
INTERVENTIONAL
Conditions
Summary
In this study, a 12-week pragmatic, randomized, double-blinded clinical trial will be conducted to evaluate the efficacy of acupuncture for the treatment of long Covid neuropsychiatric symptoms and provide reference for clinical non-drug treatment.
Eligibility
Inclusion Criteria3
- meet the clinical diagnosis of Long COVID by the World Health Organization (WHO), with no neuropsychiatric symptoms 1 year before infection with Covid-19, and continue to have at least one neuropsychiatric symptom for 2 months after SARS-CoV-2 turned negative 3 months above;
- aged 12 to 80 years;
- willing and able to consent, and complete all assessment and study procedures
Exclusion Criteria12
- patients with a history of chronic neuropsychiatric symptoms;
- cardiovascular diseases pre-existing to the Covid-19 episode such as arrhythmia, heart failure, myocardial infarction, and patients with cardiac pacemakers;
- documented pre-existing history of psychiatric illness, including substance abuse;
- suicidal tendencies (attempted suicide in the 12 months before the study);
- any chronic or remote neurological disorder (i.e. stroke, head trauma, epilepsy, tumor);
- those who participated in other clinical trials within one month;
- pregnant or lactating female patients;
- have surgery within two months before the study or will have a scheduled surgery during the study;
- acute brain injury or acute encephalopathy from another etiology than Covid-19 (e.g., sepsis, liver or renal failure, alcohol or drug withdrawal, drug toxicity);
- open-heart cardiac surgery or cardiac arrest during the last 6 months;
- patients who received acupuncture treatment 1 month before the start of the study;
- patients who were unable to complete the assessment during screening due to severe mental, cognitive, or emotional impairment
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
1. Fatigue Principal points: Pishu (BL 20), Ganshu (BL 18), Shenshu (BL 23), Baihui (GV 20), Guanyuan (RN 4), Zusanli (ST 36), Sanyinjiao (SP 6) 2. Anxiety/ depression Principal points: Yintang (EX-HN3), Baihui (GV 20), Taichong (LR 3), Neiguan (PC 6), Danzhong (RN 7) 3. Cognitive impairment/ memory loss Principal points: Baihui (GV 20), Sishencong (EX-HN1), Fengfu (GV 16), Taixi (K 13), Xuanzhong (GB 39), Zusanli (ST 36) 4. Insomnia Principal points: Zhaohai (K 16), Shenmai (BL 62), Shenmen (HT 7), Sanyinjiao (SP 6), Anmian (EX-HN22), Sishencong (EX-HN1)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06633666